Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-043029

aTYR PHARMA INC · LIFE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Farah Champsi
10% Owner
Daniel Janney
10% Owner
Guy P Nohra
10% Owner
Period of report
May 12, 2015
Accepted (ET)
May 14, 2015 · 9:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3May 12, 2015C1,685,758—A1,685,758D
Common StockF4,F5,F3May 12, 2015C92,306—A1,778,064D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Redeemable Convertible Preferred StockF3,F1,F2—May 12, 2015C3,600,000D——Common Stock452,5950D
Series B-2 Redeemable Convertible Preferred StockF3,F1,F2—May 12, 2015C4,320,173D——Common Stock543,1360D
Series C Redeemable Convertible Preferred StockF3,F1,F2—May 12, 2015C4,361,703D——Common Stock548,3560D
Series D Redeemable Convertible Preferred StockF3,F1,F2—May 12, 2015C1,126,866D——Common Stock141,6710D
Series E Redeemable Convertible Preferred StockF3,F4,F5—May 12, 2015C893,655D——Common Stock92,3060D

Explanation of responses